A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN).

Kristensen, Tilde; Birn, Henrik; Ivarsen, Per

Kristensen, Tilde; Birn, Henrik; Ivarsen, Per.

Kristensen T; Department of Internal Medicine, renal unit, Regional Hospital Viborg, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. tilde.kristensen@rm.dk.
Birn H; Department of Nephrology, Aarhus University Hospital and Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Ivarsen P; Department of Nephrology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Trials ; 22(1): 442, 2021 Jul 12.

Article en En | MEDLINE | ID: mdl-34247632

Asunto(s)

Enfermedades Renales; Nefrosis Lipoidea; Adulto; Niño; Humanos; Riñón; Nefrosis Lipoidea/diagnóstico; Nefrosis Lipoidea/tratamiento farmacológico; Prednisolona/efectos adversos; Resultado del Tratamiento; Vitamina D/efectos adversos

Palabras clave

Activated vitamin D; Adverse events; Minimal change nephropathy; Nephrotic syndrome; Pharmacokinetics; Prednisolone

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Renales / Nefrosis Lipoidea Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Adult / Child / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google